Allergy & Immunology Doctors in Rogers, AR Accepting Medicare

3 Allergy & Immunology doctors found. Showing 1 - 3

Dr. Adesua Okupa Wejinya, B.S., M.D. Allergy & Immunology - Allergy Medicare: Accepting Medicare Assignments Practice Location: 700 S 52nd St, Rogers, AR 72758 Phone: 479-464-8887

Dr. Jenny Miranda Campbell, M.D. Allergy & Immunology Medicare: Accepting Medicare Assignments Practice Location: 700 S 52nd St, Rogers, AR 72758 Phone: 479-464-8887    Fax: 479-464-9949

Dr. Curtis Lars Hedberg, MD Allergy & Immunology Medicare: Accepting Medicare Assignments Practice Location: 700 S 52nd St, Rogers, AR 72758 Phone: 479-464-8887    Fax: 479-464-9949

News Archive

Shopping abroad for cheaper medication? Here's what you need to know

In its effort to temper the sky-high prices Americans pay for many vital medications, the Trump administration last month unveiled a plan that would legalize the importation of selected prescription drugs from countries where they sell for far less.

Democrats debate public option: Publicly with GOP, and privately among themselves

Democrats are engaged in an urgent debate behind closed doors about a government-run health insurance plan, known as the public option, according to The Associated Press. "Our caucus is now in the process of negotiating with ourselves because we need all 60 of us to get this done," said Sen. Mary Landrieu, D-La., a moderate who has not yet embraced the public option concept.

Many couples willing to donate unused embryos to stem cell research

In a survey of over a thousand patients who have created and frozen embryos as part of fertility treatment, 60 percent said they would be likely to donate unused embryos for stem cell research, according to a study led by researchers at Duke University Medical Center and Johns Hopkins University.

Intermountain Healthcare participates in antibiotic stewardship forum at the White House

Intermountain Healthcare is one of 150 organizations in the nation that was invited to the White House to help develop national policy to address the growing problem of the overuse of antibiotics.

Breakthrough therapy shows promise in resistant forms of Hodgkin lymphoma

A therapy that liberates the immune system to attack cancer cells drove Hodgkin lymphoma (HL) into complete or partial remission in fully 87 percent of patients with resistant forms of the disease who participated in an early-phase clinical trial, investigators at Dana-Farber Cancer Institute and partnering institutions report in a study published today in the New England Journal of Medicine and simultaneously presented at the annual meeting of the American Society of Hematology in San Francisco.

Read more Medical News

› Verified 6 days ago